Competing with giants like Takeda and Moderna, the plucky biotech believes it has unlocked a future with an easy, yearly oral vaccine.

Each winter, communities nationwide face a surge of four main viruses that cause infections and disrupt consumers' daily lives: Influenza, Norovirus, COVID-19 and the Common Cold. Lysol calls this ...

An overlooked court decision involving postponed federal tax deadlines during the pandemic holds potential financial implications for taxpayers and businesses. Taxpayers who incurred underpayment ...

The Calibr-Skaggs Institute for Innovative Medicines at Scripps Research and Kainomyx, Inc., today announced a new research collaboration to accelerate the discovery and development of next-generation ...